Long-term follow-up of patients with acute liver failure of indeterminate aetiology

Scandinavian Journal of Gastroenterology

Volumn 43, Issue 8, 2008, Pages 984-991

  Wei, Gu ^a   Kalaitzakis, Evangelos ^a   Bergquist, Annika ^b   Björnsson, Einar ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute liver failure; Indeterminate cause; Liver transplantation; Survival

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; DISULFIRAM; ENALAPRIL; HERBACEOUS AGENT; HYDRALAZINE; IBUPROFEN; OMEPRAZOLE; PARACETAMOL; SIMVASTATIN;

ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; BILIRUBIN BLOOD LEVEL; BUDD CHIARI SYNDROME; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HEPATITIS A; HEPATITIS B; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HUMAN TISSUE; LABORATORY TEST; LIVER FAILURE; LIVER TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MUSHROOM POISONING; NEOPLASM; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; SWEDEN; WILSON DISEASE;

ACETAMINOPHEN; ADULT; ANALGESICS, NON-NARCOTIC; BUDD-CHIARI SYNDROME; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEPATITIS, VIRAL, HUMAN; HUMANS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MUSHROOM POISONING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 47949090697     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520801965399     Document Type: Article

References (14)

1. O'Grady J. Acute liver failure. In: O'Grady J, Lake J, Howdle P, editors. Comprehensive clinical hepatology, 1st ed. London: Mosby; 2000. pp 1-20.
2. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97:439-5.
3. Dhiman R, Seth A, Jain S, Chawla YK, Dilawari JB. Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis. Dig Dis Sci 1998;43:1311-6.
4. Uribe M, Buckel E, Ferrario M, Godoy J, Blanco A, Hunter B, et al. Epidemiology and results of liver transplantation for acute liver failure in Chile. Transplant Proc 2003;35:2511-2.
5. Wei G, Bergquist A, Broomé U, Lindgren S, Wallerstedt S, Almer S, et al. Acute liver failure in Sweden: etiology and outcome. J Intern Med 2007;262:393-401.
6. Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SHB, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002;137:947-55.
7. Lee WM. Acute liver failure in the United States. Semin Liver Dis 2003;23:217-26.
8. Brandsaeter B, Höckerstedt K, Friman S, Ericzon BG, Kirkegaard P, Isoniemi H, et al. Fulminant hepatic failure: outcome after listing for highly urgent liver transplantation - 12 years' experience in the Nordic countries. Liver Transpl 2002;8:1055-62.
9. Ferrac ML, Silvia AE, Macdonald GA, Tsarev SA, Di Biscelgie AM, Lucey MR. Fulminant hepatitis in patients undergoing liver transplantation: evidence for a non-A, non-B, non-C, non-D, and non-E syndrome. Liver Transpl Surg 1996;2:60-6.
10. Rochling FA, Jones WF, Chau K, DuCharme L, Mimms LT, Moore B, et al. Acute sporadic non-A, non-B, non-C, non-D, non-E hepatitis. Hepatology 1997;25:478-83.
11. Ben-Ari Z, Samuel D, Zemel R, Baruch Y, Gigou M, Sikuler E, et al. Fulminant non A-G viral hepatitis leading to liver transplantation. Arch Intern Med 2000;160:388-92.
12. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Themeau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-70.
13. Kremers WK, van Ijperen M, Kim WR, Freeman RB, Harper AM, Kamath PS, et al. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology 2004;39:764-9.
14. Bernal W, Ma Y, Smith HM, Portmann B, Wendon J, Vergani D. The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study. J Hepatol 2007;47:664-70.